Totally Future Growth
Future criteria checks 3/6
Totally is forecast to grow earnings and revenue by 148.7% and 3.1% per annum respectively while EPS is expected to grow by 154.4% per annum.
Key information
148.7%
Earnings growth rate
154.4%
EPS growth rate
| Healthcare earnings growth | 27.6% |
| Revenue growth rate | 3.1% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 06 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2026 | 95 | 2 | 3 | 6 | 1 |
| 3/31/2025 | 85 | 1 | 1 | 4 | 1 |
| 9/30/2024 | 93 | -1 | 1 | 3 | N/A |
| 6/30/2024 | 100 | -2 | 0 | 1 | N/A |
| 3/31/2024 | 107 | -3 | -2 | -1 | N/A |
| 12/31/2023 | 114 | -2 | -1 | 0 | N/A |
| 9/30/2023 | 121 | -1 | 0 | 1 | N/A |
| 6/30/2023 | 128 | 0 | -2 | 0 | N/A |
| 3/31/2023 | 136 | 2 | -3 | -2 | N/A |
| 12/31/2022 | 136 | 1 | -2 | -1 | N/A |
| 9/30/2022 | 136 | 1 | -1 | 0 | N/A |
| 6/30/2022 | 132 | 1 | 4 | 6 | N/A |
| 3/31/2022 | 127 | 1 | 10 | 11 | N/A |
| 12/31/2021 | 124 | 1 | 9 | 10 | N/A |
| 9/30/2021 | 121 | 1 | 8 | 9 | N/A |
| 6/30/2021 | 117 | 1 | 8 | 9 | N/A |
| 3/31/2021 | 114 | 0 | 8 | 9 | N/A |
| 12/31/2020 | 112 | 0 | 7 | 9 | N/A |
| 9/30/2020 | 111 | 0 | 6 | 8 | N/A |
| 6/30/2020 | 108 | -2 | 4 | 5 | N/A |
| 3/31/2020 | 106 | -3 | 2 | 3 | N/A |
| 12/31/2019 | 97 | -3 | 0 | 1 | N/A |
| 9/30/2019 | 87 | -3 | -2 | -1 | N/A |
| 6/30/2019 | 83 | -2 | -2 | -1 | N/A |
| 3/31/2019 | 78 | -2 | -3 | -2 | N/A |
| 9/30/2018 | 71 | 2 | -4 | -3 | N/A |
| 6/30/2018 | 52 | 2 | N/A | -3 | N/A |
| 3/31/2018 | 34 | 1 | N/A | -3 | N/A |
| 12/31/2017 | 21 | -2 | N/A | -3 | N/A |
| 9/30/2017 | 14 | -2 | N/A | -3 | N/A |
| 6/30/2017 | 7 | -2 | N/A | -2 | N/A |
| 3/31/2017 | 5 | -2 | N/A | -2 | N/A |
| 12/31/2016 | 4 | -2 | N/A | -2 | N/A |
| 9/30/2016 | 3 | -1 | N/A | -2 | N/A |
| 6/30/2016 | 1 | -1 | N/A | -1 | N/A |
| 3/31/2016 | 1 | -1 | N/A | -1 | N/A |
| 12/31/2015 | 1 | 0 | N/A | -1 | N/A |
| 9/30/2015 | 1 | 0 | N/A | 0 | N/A |
| 6/30/2015 | 1 | 0 | N/A | 0 | N/A |
| 3/31/2015 | 1 | 0 | N/A | 0 | N/A |
| 12/31/2014 | 1 | 0 | N/A | 0 | N/A |
| 6/30/2014 | 0 | -1 | N/A | -1 | N/A |
| 3/31/2014 | 1 | -1 | N/A | -1 | N/A |
| 12/31/2013 | 1 | -1 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: UKXA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: UKXA is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: UKXA is expected to become profitable in the next 3 years.
Revenue vs Market: UKXA's revenue (3.1% per year) is forecast to grow slower than the German market (5.6% per year).
High Growth Revenue: UKXA's revenue (3.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if UKXA's Return on Equity is forecast to be high in 3 years time